FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387472232> ?p ?o ?g. }

• W4387472232 endingPage "18" @default.
• W4387472232 startingPage "1" @default.
• W4387472232 abstract "The present study aims to examine the structural requirements governing α-amylase inhibitory activity of 5-(3-arylallylidene)-2-(arylimino)thiazolidin-4-one derivatives and their precursors by employing a multifaceted approach combining in vitro and in silico studies. The in vitro assay findings revealed strong inhibitory effect of this class of compounds against α-amylase and compound 20 exhibited maximum percentage inhibition of 88.54 ± 0.69, 84.98 ± 0.40, 77.26 ± 0.75, 67.80 ± 0.54, and 62.93 ± 1.17 at 200, 100, 50, 25, and 12.5 µg mL-1, respectively. Multiple CORAL QSAR models were developed from the randomly distributed eight splits by employing two target functions (TF1, TF2 with WCII = 0.0 and = 0.3, respectively), and the quality of predictions by the produced models was validated with the help of various statistical parameters. The model M-4 (R2Val = 0.8799) and model M-11 (R2Val = 0.9064) were the leading models developed by using TF1 and TF2. We designed five new congeneric inhibitors (D-1 to D-5) by incorporating SMILES features positively correlating with the activity. Molecular docking experiments were carried out to confirm the binding of these new inhibitors with the biological receptor α-amylase (PDB ID: 7TAA). Furthermore, molecular dynamic simulations provided a thorough knowledge of the binding process by shedding insight into the dynamic behavior and stability of the ligand-receptor complex over time. The results of this study highlight the key structural characteristics needed for improved α-amylase inhibitory efficacy and provide a rational basis for the development of more effective inhibitors.Communicated by Ramaswamy H. Sarma." @default.
• W4387472232 created "2023-10-11" @default.
• W4387472232 creator A5001796735 @default.
• W4387472232 creator A5013946867 @default.
• W4387472232 creator A5036858021 @default.
• W4387472232 creator A5044054248 @default.
• W4387472232 creator A5084077488 @default.
• W4387472232 date "2023-10-10" @default.
• W4387472232 modified "2023-10-16" @default.
• W4387472232 title "CORAL: probing the structural requirements for α-amylase inhibition activity of 5-(3-arylallylidene)-2-(arylimino)thiazolidin-4-one derivatives based on QSAR with correlation intensity index, molecular docking, molecular dynamics, and ADMET studies" @default.
• W4387472232 cites W2014858249 @default.
• W4387472232 cites W2029667189 @default.
• W4387472232 cites W2762849219 @default.
• W4387472232 cites W2897438806 @default.
• W4387472232 cites W2907075557 @default.
• W4387472232 cites W2972485984 @default.
• W4387472232 cites W2985233215 @default.
• W4387472232 cites W2992059490 @default.
• W4387472232 cites W2995395833 @default.
• W4387472232 cites W2996305798 @default.
• W4387472232 cites W2997160604 @default.
• W4387472232 cites W2999330643 @default.
• W4387472232 cites W3012770371 @default.
• W4387472232 cites W3019103367 @default.
• W4387472232 cites W3024545198 @default.
• W4387472232 cites W3025480423 @default.
• W4387472232 cites W3026720690 @default.
• W4387472232 cites W3033814734 @default.
• W4387472232 cites W3046227393 @default.
• W4387472232 cites W3080521078 @default.
• W4387472232 cites W3081839587 @default.
• W4387472232 cites W3092160384 @default.
• W4387472232 cites W3117659384 @default.
• W4387472232 cites W3126163513 @default.
• W4387472232 cites W3135098857 @default.
• W4387472232 cites W3154258817 @default.
• W4387472232 cites W3163917991 @default.
• W4387472232 cites W3172747904 @default.
• W4387472232 cites W3180327968 @default.
• W4387472232 cites W3182055317 @default.
• W4387472232 cites W3191098620 @default.
• W4387472232 cites W3196609471 @default.
• W4387472232 cites W3199793362 @default.
• W4387472232 cites W3201605176 @default.
• W4387472232 cites W3205344020 @default.
• W4387472232 cites W3207287796 @default.
• W4387472232 cites W3210727002 @default.
• W4387472232 cites W4200154131 @default.
• W4387472232 cites W4205174124 @default.
• W4387472232 cites W4207075344 @default.
• W4387472232 cites W4207082026 @default.
• W4387472232 cites W4210789006 @default.
• W4387472232 cites W4220751635 @default.
• W4387472232 cites W4220885652 @default.
• W4387472232 cites W4221062422 @default.
• W4387472232 cites W4225294462 @default.
• W4387472232 cites W4229069131 @default.
• W4387472232 cites W4285165875 @default.
• W4387472232 cites W4286426680 @default.
• W4387472232 cites W4288046649 @default.
• W4387472232 cites W4291290217 @default.
• W4387472232 cites W4293434244 @default.
• W4387472232 cites W4295271055 @default.
• W4387472232 cites W4296416804 @default.
• W4387472232 cites W4307941926 @default.
• W4387472232 cites W4307954487 @default.
• W4387472232 cites W4309116389 @default.
• W4387472232 cites W4315796725 @default.
• W4387472232 cites W4319781385 @default.
• W4387472232 cites W4320180791 @default.
• W4387472232 cites W4320732441 @default.
• W4387472232 cites W4321379978 @default.
• W4387472232 cites W4322012143 @default.
• W4387472232 cites W4323304766 @default.
• W4387472232 cites W4362579579 @default.
• W4387472232 doi "https://doi.org/10.1080/07391102.2023.2265490" @default.
• W4387472232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37815000" @default.
• W4387472232 hasPublicationYear "2023" @default.
• W4387472232 type Work @default.
• W4387472232 citedByCount "0" @default.
• W4387472232 crossrefType "journal-article" @default.
• W4387472232 hasAuthorship W4387472232A5001796735 @default.
• W4387472232 hasAuthorship W4387472232A5013946867 @default.
• W4387472232 hasAuthorship W4387472232A5036858021 @default.
• W4387472232 hasAuthorship W4387472232A5044054248 @default.
• W4387472232 hasAuthorship W4387472232A5084077488 @default.
• W4387472232 hasConcept C104317684 @default.
• W4387472232 hasConcept C147597530 @default.
• W4387472232 hasConcept C159110408 @default.
• W4387472232 hasConcept C164126121 @default.
• W4387472232 hasConcept C170835558 @default.
• W4387472232 hasConcept C181199279 @default.
• W4387472232 hasConcept C185592680 @default.
• W4387472232 hasConcept C2775905019 @default.
• W4387472232 hasConcept C41685203 @default.
• W4387472232 hasConcept C55493867 @default.
• W4387472232 hasConcept C59593255 @default.
• W4387472232 hasConcept C65556437 @default.

• next